Member LoginDividend CushionValue Trap |
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for
any changes.
Apr 9, 2015
The Time to Consider Owning Alcoa Has Passed
Alcoa’s acquisition spree has made it an attractive merger candidate. Mar 5, 2015
Sorry Gold Bugs
Buying the yellow metal is just playing the "greater fool" game. Feb 8, 2015
Dividend Increases/Decreases for the Week Ending February 6
Let's take a look at dividend increases/decreases for the week ending February 6. Jan 17, 2015
Yes, We Had Removed PCP Before the Fall
Precision Castparts, one of our favorite companies on the watch list, has an enviable position in aerospace. Its energy exposure, however, is impeding profit expansion. Jan 14, 2015
BHP or Rio Tinto? Is That the Right Question?
We only have modest exposure to the highly volatile commodities markets...for this very reason. Jan 13, 2015
Alcoa Kicks Off Fourth Quarter Earnings Season
The aluminum giant has its hands in a lot of end markets. Let’s take a look at its fourth-quarter results to get an early read on pockets of strength in the fourth quarter. Dec 26, 2014
HCV Competition Not New “News” for Gilead
Gilead is trading more than 40% above its 52-week low and about 20% from its 52-week high. We see no reason to panic, and the company’s trading activity more closely reflects a company whose stock price has quintupled in recent years than one that is in any trouble whatsoever. Gilead’s shares bounced right off technical support levels, and we see a long term that is still very bright for the biotech. Gilead’s shares remain underpriced even under a bear-case scenario. Nov 29, 2014
$45 Oil Prices!?!? There Is Never a Sense of Urgency When One Is Prepared
Friday brought mass selling across the energy sector. In our view, crude oil prices could hit $45 per barrel in the next few years before recovering. Oct 29, 2014
Gilead’s Revenue More Than Doubles in Third Quarter
Antiviral sales at the company remain strong, and we continue to like opportunities in its pipeline. Oct 15, 2014
Johnson & Johnson: Still a Solid Dividend Growth Pick
We have no plans to remove Johnson & Johnson from the Dividend Growth portfolio. The High Yield Dividend Newsletter, Best Ideas
Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on
this website are for information purposes only and should not be considered a solicitation to buy or sell any
security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s
accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or
omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts
no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a
registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees,
and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.
|